Author:
Li Yuanyuan,Xiang Ying,Mou Bo,Song Xiusheng
Funder
Enshi Science and Technology Program
Publisher
Springer Science and Business Media LLC
Reference52 articles.
1. Qaum T, Xu Q, Joussen AM, Clemens MW, Qin W, Miyamoto K, et al. VEGF-initiated blood-retinal barrier breakdown in early diabetes. Invest Ophthalmol Vis Sci. 2001;42(10):2408–13.
2. Ahsan H. Diabetic retinopathy – biomolecules and multiple pathophysiology. Diabetes Metabolic Syndrome: Clin Res Reviews. 2015;9(1):51–4.
3. Yue T, Shi Y, Luo S, Weng J, Wu Y, Zheng X. The role of inflammation in immune system of diabetic retinopathy: molecular mechanisms, pathogenetic role and therapeutic implications. Front Immunol. 2022;13:1055087.
4. Yau JWY, Rogers SL, Kawasaki R, Lamoureux EL, Kowalski JW, Bek T, et al. Global prevalence and major risk factors of Diabetic Retinopathy. Diabetes Care. 2012;35(3):556–64.
5. Teo ZL, Tham Y-C, Yu M, Chee ML, Rim TH, Cheung N, et al. Global prevalence of Diabetic Retinopathy and Projection of Burden through 2045. Ophthalmology. 2021;128(11):1580–91.